Literature DB >> 4748450

Chemotherapy of malignant lymphoma with adriamycin.

J A Gottlieb, J U Gutterman, K B McCredie, V Rodriguez, E Frei.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4748450

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  12 in total

1.  The natural history of non-Hodgkin's lymphomata stages I and II.

Authors:  L M Fuller; F L Banker; J J Butler; J F Gamble; M P Sullivan
Journal:  Br J Cancer Suppl       Date:  1975-03

2.  High expression of Bcl-2 predicts poor outcome in diffuse large B-cell lymphoma patients with low international prognostic index receiving R-CHOP chemotherapy.

Authors:  Yong Won Choi; Mi Sun Ahn; Jin-Hyuk Choi; Hyun Woo Lee; Seok Yun Kang; Seong Hyun Jeong; Joon Seong Park; Jae Ho Han; Jang-Hee Kim; Seung Soo Sheen
Journal:  Int J Hematol       Date:  2015-11-19       Impact factor: 2.490

3.  Plasma ACTH and melanocyte-stimulating hormone in nail pigmentation.

Authors:  S Arakawa; T Takamatsu; S Imashuku; T Kusunoki
Journal:  Arch Dis Child       Date:  1978-03       Impact factor: 3.791

4.  How to determine post-RCHOP therapy for risk-tailored adult patients with diffuse large B-cell lymphoma, addition of maintenance rituximab or observation: multicenter experience.

Authors:  Bin-Tao Huang; Qing-Chun Zeng; Jessica Yu; Zhen Xiao; Bing-Sheng Li; Chun-Lai Zhang; Hong-Bo Ji
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-06       Impact factor: 4.553

5.  New agents and combination chemotherapy of non-Hodgkin's lymphoma.

Authors:  A T Skarin; E Frei; W C Moloney; J U Gutterman
Journal:  Br J Cancer Suppl       Date:  1975-03

6.  Treatment outcomes in AIDS-related diffuse large B-cell lymphoma in the setting roll out of combination antiretroviral therapy in South Africa.

Authors:  Pieter de Witt; Deborah J Maartens; Thomas S Uldrick; Gerhard Sissolak
Journal:  J Acquir Immune Defic Syndr       Date:  2013-09-01       Impact factor: 3.731

Review 7.  Extravascular use of drug-eluting beads: a promising approach in compartment-based tumor therapy.

Authors:  Simon Binder; Andrew L Lewis; J-Matthias Löhr; Michael Keese
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

8.  Beta-adrenergic receptor mediated protection against doxorubicin-induced apoptosis in cardiomyocytes: the impact of high ambient glucose.

Authors:  Naohiro Yano; Daisuke Suzuki; Masayuki Endoh; Andy Tseng; Joan P Stabila; Bethany G McGonnigal; Ting C Zhao; James F Padbury; Yi-Tang Tseng
Journal:  Endocrinology       Date:  2008-08-21       Impact factor: 4.736

9.  Metformin protects cardiomyocyte from doxorubicin induced cytotoxicity through an AMP-activated protein kinase dependent signaling pathway: an in vitro study.

Authors:  Laura C Kobashigawa; Yan Chun Xu; James F Padbury; Yi-Tang Tseng; Naohiro Yano
Journal:  PLoS One       Date:  2014-08-15       Impact factor: 3.240

Review 10.  High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive non-Hodgkin lymphoma (NHL) in adults.

Authors:  A Greb; J Bohlius; D Schiefer; G Schwarzer; H Schulz; A Engert
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.